chr19-51340697-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001163922.3(VSIG10L):āc.925A>Gā(p.Lys309Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000734 in 1,362,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001163922.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSIG10L | NM_001163922.3 | c.925A>G | p.Lys309Glu | missense_variant | 3/10 | ENST00000335624.5 | NP_001157394.1 | |
VSIG10L-AS1 | NR_186316.1 | n.678T>C | non_coding_transcript_exon_variant | 1/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSIG10L | ENST00000335624.5 | c.925A>G | p.Lys309Glu | missense_variant | 3/10 | 5 | NM_001163922.3 | ENSP00000335623.3 | ||
VSIG10L-AS1 | ENST00000594311.1 | n.3T>C | non_coding_transcript_exon_variant | 1/4 | 5 | |||||
VSIG10L-AS1 | ENST00000601148.5 | n.3T>C | non_coding_transcript_exon_variant | 1/5 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 7.34e-7 AC: 1AN: 1362188Hom.: 0 Cov.: 34 AF XY: 0.00000149 AC XY: 1AN XY: 669368
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2023 | The c.925A>G (p.K309E) alteration is located in exon 3 (coding exon 3) of the VSIG10L gene. This alteration results from a A to G substitution at nucleotide position 925, causing the lysine (K) at amino acid position 309 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.